1
|
Miller RJH, Kavanagh P, Lemley M, Liang JX, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Hayes S, Friedman J, Berman DS, Dey D, Slomka PJ. Artificial Intelligence-Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion Imaging. J Nucl Med 2025; 66:648-653. [PMID: 39978815 PMCID: PMC11960614 DOI: 10.2967/jnumed.124.268079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 01/29/2025] [Indexed: 02/22/2025] Open
Abstract
We previously demonstrated that a deep learning (DL) model of myocardial perfusion SPECT imaging improved accuracy for detection of obstructive coronary artery disease (CAD). We aimed to improve the clinical translatability of this artificial intelligence (AI) approach using the results to derive enhanced total perfusion deficit (TPD) and 17-segment summed scores. Methods: We used a cohort of patients undergoing myocardial perfusion imaging within 180 d of invasive coronary angiography. Obstructive CAD was defined as any stenosis of at least 70% or at least 50% in the left main coronary artery. We used per-vessel DL predictions to modulate polar map pixel scores. These transformed polar maps were then used to derive TPD-DL and summed stress score-DL. We compared diagnostic performance using area under the receiver operating characteristic curve (AUC). Results: In the 555 patients held out for testing, the median age was 65 y (interquartile range, 57-73 y), and 381 (69%) were male. Obstructive CAD was present in 329 (59%) patients. The prediction performance for obstructive CAD of stress TPD-DL (AUC, 0.837; 95% CI, 0.804-0.870) was higher than AI prediction alone (AUC, 0.795; 95% CI, 0.758-0.831; P = 0.005) and traditional stress TPD (AUC, 0.737; 95% CI, 0.696-0.778; P < 0.001). Summed stress score-DL had the second highest prediction performance (AUC, 0.822; 95% CI, 0.788-0.857) and higher AUC than traditional quantitative summed stress score (AUC, 0.728; 95% CI, 0.686-0.769; P < 0.001). At a threshold of 5%, the sensitivity and specificity of TPD rose from 72% to 79% and from 62% to 70%, respectively. Conclusion: Integrating AI predictions with traditional quantitative approaches leads to a simplified AI approach, presenting clinicians with familiar measures but operating with higher accuracy than traditional quantitative scoring. This approach may facilitate integration of new AI methods into clinical practice.
Collapse
Affiliation(s)
- Robert J H Miller
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
- Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada
| | - Paul Kavanagh
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Mark Lemley
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Joanna X Liang
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Tali Sharir
- Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, Israel, and Ben Gurion University of the Negev, Beer Sheba, Israel
| | - Andrew J Einstein
- Division of Cardiology, Departments of Medicine, and Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York
| | - Mathews B Fish
- Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, Oregon
| | - Terrence D Ruddy
- Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
| | - Philipp A Kaufmann
- Cardiac Imaging, Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
| | - Albert J Sinusas
- Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
| | - Edward J Miller
- Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
| | | | - Sharmila Dorbala
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts
| | - Marcelo Di Carli
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts
| | - Sean Hayes
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - John Friedman
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Daniel S Berman
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Damini Dey
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California
| | - Piotr J Slomka
- Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California;
| |
Collapse
|
2
|
Miller RJH, Slomka PJ. Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends. Semin Nucl Med 2024; 54:648-657. [PMID: 38521708 DOI: 10.1053/j.semnuclmed.2024.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2024] [Accepted: 02/19/2024] [Indexed: 03/25/2024]
Abstract
Myocardial perfusion imaging (MPI), using either single photon emission computed tomography (SPECT) or positron emission tomography (PET), is one of the most commonly ordered cardiac imaging tests, with prominent clinical roles for disease diagnosis and risk prediction. Artificial intelligence (AI) could potentially play a role in many steps along the typical MPI workflow, from image acquisition through to clinical reporting and risk estimation. AI can be utilized to improve image quality, reducing radiation exposure and image acquisition times. Once images are acquired, AI can help optimize motion correction and image registration during image reconstruction or provide direct image attenuation correction. Utilizing these image sets, AI can segment a number of anatomic features from associated computed tomographic imaging or even generate synthetic attenuation imaging. Lastly, AI may play an important role in disease diagnosis or risk prediction by combining the large number of potentially important clinical, stress, and imaging-related variables. This review will focus on the most recent developments in the field, providing clinicians and researchers with a timely update on the field. Additionally, it will discuss future trends including applications of AI during multiple points of the typical MPI workflow to maximize clinical utility and methods to maximize the information that can be obtained from hybrid imaging.
Collapse
Affiliation(s)
- Robert J H Miller
- Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA; Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada
| | - Piotr J Slomka
- Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA.
| |
Collapse
|
3
|
Miller RJH, Slomka PJ. Current status and future directions in artificial intelligence for nuclear cardiology. Expert Rev Cardiovasc Ther 2024; 22:367-378. [PMID: 39001698 DOI: 10.1080/14779072.2024.2380764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Accepted: 07/12/2024] [Indexed: 07/18/2024]
Abstract
INTRODUCTION Myocardial perfusion imaging (MPI) is one of the most commonly ordered cardiac imaging tests. Accurate motion correction, image registration, and reconstruction are critical for high-quality imaging, but this can be technically challenging and has traditionally relied on expert manual processing. With accurate processing, there is a rich variety of clinical, stress, functional, and anatomic data that can be integrated to guide patient management. AREAS COVERED PubMed and Google Scholar were reviewed for articles related to artificial intelligence in nuclear cardiology published between 2020 and 2024. We will outline the prominent roles for artificial intelligence (AI) solutions to provide motion correction, image registration, and reconstruction. We will review the role for AI in extracting anatomic data for hybrid MPI which is otherwise neglected. Lastly, we will discuss AI methods to integrate the wealth of data to improve disease diagnosis or risk stratification. EXPERT OPINION There is growing evidence that AI will transform the performance of MPI by automating and improving on aspects of image acquisition and reconstruction. Physicians and researchers will need to understand the potential strengths of AI in order to benefit from the full clinical utility of MPI.
Collapse
Affiliation(s)
- Robert J H Miller
- Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Department of Cardiac Sciences, University of Calgary, Calgary, Canada
| | - Piotr J Slomka
- Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| |
Collapse
|